Investors & Media
The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. To learn more about The Medicines Company and our work driving innovation in the cardiovascular disease space, visit our media toolkit here.
Press Releases
18 Nov 2019The Medicines Company Announces that the ORION-9 Study of Inclisiran in HeFH Patients Showed Durable and Potent LDL-C Lowering with Twice-Yearly Dosing16 Nov 2019The Medicines Company Announces that the ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing06 Nov 2019The Medicines Company to Present Inclisiran Data from ORION-9 and ORION-10 Pivotal Phase 3 Clinical Studies at American Heart Association Scientific Sessions 2019
View AllEvents & Presentations
Upcoming Events
There are no upcoming events at this time. Please check back.